Caris Life Sciences, Inc. (CAI) stock
CAINasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 7/3093% above fair value
$19.50−0.44 (-2.21%)
Close on Nov 18, 2026Market cap $5.51BP/E –Yield –
Caris Life Sciences market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Caris Life Sciences's market cap was $6.92B on Nov 11, 2026, against $7.20B a year earlier.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $6.92B | -9.1% |
| 2025 | Dec 31, 2025 | $7.61B | – |
See a number that looks wrong?